Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_assertion type Assertion NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_head.
- NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_provenance.
- NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_assertion evidence source_evidence_literature NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_provenance.
- NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_assertion SIO_000772 23546520 NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_provenance.
- NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_assertion wasDerivedFrom befree-20140225 NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_provenance.
- NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_assertion wasGeneratedBy ECO_0000203 NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_provenance.